Heron Therapeutics Inc (NASDAQ: HRTX) on Tuesday, soared 0.43% from the previous trading day, before settling in for the closing price of $2.33. Within the past 52 weeks, HRTX’s price has moved between $1.04 and $3.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.88% over the last five years. The company achieved an average annual earnings per share of 81.81%. With a float of $150.92 million, this company’s outstanding shares have now reached $152.13 million.
The firm has a total of 122 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.71%, operating margin of -7.5%, and the pretax margin is -8.83%.
Heron Therapeutics Inc (HRTX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Heron Therapeutics Inc is 0.93%, while institutional ownership is 75.50%.
Heron Therapeutics Inc (HRTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.81% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Heron Therapeutics Inc (HRTX) is currently performing well based on its current performance indicators. A quick ratio of 1.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach 0.10 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Analysing the last 5-days average volume posted by the [Heron Therapeutics Inc, HRTX], we can find that recorded value of 1.02 million was lower than the volume posted last year of 1.61 million. As of the previous 9 days, the stock’s Stochastic %D was 87.16%. Additionally, its Average True Range was 0.15.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 78.06%, which indicates a significant decrease from 89.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.41% in the past 14 days, which was lower than the 93.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.14, while its 200-day Moving Average is $1.95. Now, the first resistance to watch is $2.40. This is followed by the second major resistance level at $2.47. The third major resistance level sits at $2.52. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.24. Now, if the price goes above the second support level, the third support stands at $2.17.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
Market capitalization of the company is 356.45 million based on 152,330K outstanding shares. Right now, sales total 144,290 K and income totals -13,580 K. The company made 40,780 K in profit during its latest quarter, and 3,660 K in sales during its previous quarter.
